1. Home
  2. TXT vs GMAB Comparison

TXT vs GMAB Comparison

Compare TXT & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Textron Inc.

TXT

Textron Inc.

HOLD

Current Price

$83.47

Market Cap

14.5B

Sector

Industrials

ML Signal

HOLD

Logo Genmab A/S ADS

GMAB

Genmab A/S ADS

HOLD

Current Price

$31.74

Market Cap

17.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXT
GMAB
Founded
1923
1999
Country
United States
Denmark
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5B
17.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TXT
GMAB
Price
$83.47
$31.74
Analyst Decision
Buy
Strong Buy
Analyst Count
11
6
Target Price
$92.45
$40.40
AVG Volume (30 Days)
1.2M
1.4M
Earning Date
01-21-2026
11-06-2025
Dividend Yield
0.10%
N/A
EPS Growth
N/A
132.41
EPS
4.55
25.10
Revenue
$14,237,000,000.00
$3,845,670,022.00
Revenue This Year
$8.63
$24.85
Revenue Next Year
$4.95
$16.67
P/E Ratio
$18.34
$12.31
Revenue Growth
1.83
29.57
52 Week Low
$57.70
$17.24
52 Week High
$87.94
$33.65

Technical Indicators

Market Signals
Indicator
TXT
GMAB
Relative Strength Index (RSI) 58.23 59.84
Support Level $81.54 $31.32
Resistance Level $84.49 $32.41
Average True Range (ATR) 1.40 0.64
MACD 0.28 0.11
Stochastic Oscillator 81.35 73.67

Price Performance

Historical Comparison
TXT
GMAB

About TXT Textron Inc.

Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial contains the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts and all-terrain vehicles.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: